3Ito S,Shirai W,Hattori T.Putaminal hyperintensity on T1-Weighted MR imaging in patients with the parkinson variant of multiple system atrophy[J].AJNR Am J Neuroradio,2009,30(4):689-692.
4Auer DP.In vivo imaging markers of neurodegeneration of the substantia nigra[J].Exp Geronto,2009,44(1-2):4-9.
5Matsusue E,Ogawa T.Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field[J].Brain Nerve,2007,59(5):479-485.
6Goebel G,Seppi K,Donnemiller E,et al.A novel computer-assisted image analysis of[(123)I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders[J].Eur J Nucl Med Mol Imaging,2010,20:1145-1156.
7Eapen M,Zald DH,Gatenby JC,et al.Using High-Resolution MR Imaging at 7T to Evaluate the Anatomy of the Midbrain Dopaminergic System[J].AJNR Am J Neuroradiol,2010,23:688.
8Jokinen P,Helenius H,Rauhala E,et al.Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls[J].J Nucl Med,2009,50(6):893-899.
